Mr Albert Hung-pei Luh, MD in Longview, WA - Medicare Family Medicine

Mr Albert Hung-pei Luh, MD is a medicare enrolled "Family Medicine" physician in Longview, Washington. His current practice location is 1230 7th Ave, Longview, Washington. You can reach out to his office (for appointments etc.) via phone at (360) 575-4801.

Mr Albert Hung-pei Luh is licensed to practice in Washington (license number WA MD0002774) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1033122528.

Contact Information

	Mr Albert Hung-pei Luh, MD
	1230 7th Ave, Longview, WA 98632-3166
	(360) 575-4801
	Not Available

Physician's Profile

Full Name	Mr Albert Hung-pei Luh
Gender	Male
Speciality	Family Medicine
Location	1230 7th Ave, Longview, Washington
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1033122528
Provider Enumeration Date: 08/14/2006
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 3779674171
Enrollment ID: I20070814000120

Medical Identifiers

Medical identifiers for Mr Albert Hung-pei Luh such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033122528	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	WA MD0002774 (Washington)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mr Albert Hung-pei Luh allows following entities to bill medicare on his behalf.

Entity Name	Kaiser Foundation Health Plan Of The Northwest
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040220000099

News Archive

Oncolytics announces completion of patient enrollment in REOLYSIN Phase II colorectal cancer study

Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer (IND 210). The trial is being sponsored and conducted by the NCIC Clinical Trials Group at Queen's University in Kingston, Ontario.

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Arrowhead Research Corporation today announced that it has executed an exclusive world-wide license on technology developed by Drs. Wadih Arap and Renata Pasqualini at MD Anderson Cancer Center for use in weight loss and obesity-related metabolic conditions, and that it has launched a new company, Ablaris Therapeutics Inc., to commercialize this platform.

Powerful new discovery method speeds up gene discovery

Scientists will be able to pinpoint genetic causes of human diseases faster than ever thanks to a powerful new discovery method unveiled by the Southwest Foundation for Biomedical Research (SFBR) and an international team of researchers.

Novel strategy for stimulating the production of utrophin

Researchers at the University of Pennsylvania School of Medicine report a novel strategy for stimulating the production of utrophin – an important muscle protein in young mice – for muscular dystrophy therapy.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Albert Hung-pei Luh is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Albert Hung-pei Luh, MD 471 Lone Oak Rd, Longview, WA 98632-9575 Ph: (360) 578-9879	Mr Albert Hung-pei Luh, MD 1230 7th Ave, Longview, WA 98632-3166 Ph: (360) 575-4801

News Archive

Oncolytics announces completion of patient enrollment in REOLYSIN Phase II colorectal cancer study

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Powerful new discovery method speeds up gene discovery

Novel strategy for stimulating the production of utrophin

Family Medicine Doctors in Longview, WA

Michael Adam Krall, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1230 7th Ave, Longview, WA 98632 Phone: 360-575-4801
Dr. Joseph Leslie Davis, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2807 36th Ave, Longview, WA 98632 Phone: 360-425-8365
Muhammad Riaz, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-7800 Fax: 360-414-7808
Dr. Morgan Daneel Evans, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1718 E Kessler Blvd, Longview, WA 98632 Phone: 360-747-5800 Fax: 360-575-3846
Mu-hsiang Joy Wang, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1718 E Kessler Blvd, Longview, WA 98632 Phone: 360-747-5800 Fax: 360-575-3846
Peter W Dicristina, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1230 7th Ave, Longview, WA 98632 Phone: 360-636-2400

Mr Albert Hung-pei Luh, MD - Medicare Family Medicine in Longview, WA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Oncolytics announces completion of patient enrollment in REOLYSIN Phase II colorectal cancer study

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Powerful new discovery method speeds up gene discovery

Novel strategy for stimulating the production of utrophin

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Oncolytics announces completion of patient enrollment in REOLYSIN Phase II colorectal cancer study

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Powerful new discovery method speeds up gene discovery

Novel strategy for stimulating the production of utrophin

Family Medicine Doctors in Longview, WA